Back to Agenda
Session 6, Track B: Canada Now – Together
Session Chair(s)
Rebecca Barnes, MS
Executive Director
Network of Networks (N2), Canada
Manitoba reviewed its clinical trials system using human-centered design and lean methods to make it more predictable, efficient, and aligned with provincial strengths. A working group of researchers, industry, government, and academia identified that trial activity remains below pre-COVID levels. The review focused on time to conduct, patient engagement, infrastructure, and partnerships, leading to key recommendations. Outcomes include streamlined processes, rural engagement strategies, infrastructure needs, and new partnership opportunities to support a stronger research environment.
- Advancing Clinical Trials in Manitoba: Towards a Pan-Canadian Approach
Andrea Ladouceur, Bioscience Association of Manitoba - Canada Now Together
Suzie Talbot, Diex Research - Patient Voice: Enhancing Clinical Trial Impact
Ursula Mann, Patient Voice Partners
Learning Objective :
At the conclusion of this session, participants should be able to:
- Increase understanding of clinical trials from the perspectives of: patients; industry access and economic development; and health innovation
- Identify the value of clinical trials from these perspectives and how a pan-Canadian approach can support advancement in trials and possibly adoption (rooted in the recent Manitoba experience)
Speaker(s)
Canada Now Together
Suzie Talbot, MBA, RN
Diex Research, Canada
President
Advancing Clinical Trials in Manitoba: Towards a Pan-Canadian Approach
Ursula Mann, BSN
Patient Voice Partners, Canada
Principal and Chief Patient Officer (CPO)
Canada Now - Together
Andrea Ladouceur
Bioscience Association of Manitoba, Canada
President and CEO
Have an account?